16.44BMarket Cap
35.57P/E TTM
Medpace Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Medpace Holdings Inc is 9.83, ranking 5 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 35.57, which is 26.29% below the recent high of 44.93 and 42.31% above the recent low of 20.52.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.